Skip to content

Neonatal Experience of Social Touch

The Healing Power of Touch: Investigation of a Peripheral Neurological Mechanism for Reducing Pain and Enhancing Neurodevelopmental Outcomes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05039918
Acronym
NEST
Enrollment
40
Registered
2021-09-10
Start date
2021-09-30
Completion date
2022-03-31
Last updated
2021-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Development, Pain, Premature Birth

Keywords

CT Fibres, Affective touch

Brief summary

The purpose of this randomised control trial is to determine the efficacy of CT-optimal touch (gentle stroking at 3cm/s) for newborn's who require a heel prick.

Detailed description

Newborn infants are subject to several novel experiences that cause physiological, biochemical and behavioural indicators of stress; even routine and common events such as handling, changing a diaper or being bathed can increase salivary cortisol levels. Excluding surgery and mechanical ventilation, the most common procedural pain sources in newborns are heel-lancing and venepuncture. Tactile interventions such as skin to skin care and 'still containment hold' are widely used in clinical care with apparent positive results such as lower mean respiratory heart rate and pain measures, and higher oxygen saturation; yet, dynamic touch interventions have reported to be more beneficial than static touch interventions. A distinct type of nerve fibres, CT (C tactile) afferents, found exclusively in hairy skin, that respond optimally to gentle stroking at a velocity of \ 1-10cm/s, are part of a system for processing pleasant and social rewarding touch. CT fibre activation also plays a role in pain inhibition and may be linked to the development of self-regulation, thereby, serving a neuroprotective function for the developing infant brain. Here we will investigate whether tactile stimulation at CT-optimal velocity will reduce biochemical and physiological indicators of stress in infants, as determined by salivary cortisol, heart rate and blood oxygenation levels.

Interventions

BEHAVIORALAffective touch

Gentle stroking at CT-optimal speed

Sponsors

Liverpool Women's NHS Foundation Trust
CollaboratorOTHER
Liverpool John Moores University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

Allocation sequence will be randomised in advance by a trusted member of LJMU staff who is not involved in the study, using a computerised website to generate random numbers. The sequences will be placed in sealed opaque envelopes and stored in a secure location on-site. The use of an off-site computerised system for group allocation will decrease the risk of allocation bias. Eligible infants whose person(s) with parental responsibility have provided consent will be assigned the next available envelope which will be accessed by the lead researcher prior to the intervention.

Eligibility

Sex/Gender
ALL
Age
35 Weeks to 42 Weeks
Healthy volunteers
Yes

Inclusion criteria

* The infant is born between 35 and 42 weeks. * Require a heel prick * Infants may be treated with antibiotics. * Infants may be supported with non-invasive respiratory support. * Infants may require blood sugar monitoring. * Infants may be monitored for jaundice or infection. * Written consent has been obtained from the person(s) with parental responsibility.

Exclusion criteria

* Have a history of neurological problems. * Receiving pharmacological analgesics. * Known genetic condition. * Breastfed babies * Admitted to high dependency or intensive care * Invasive respiratory support * Receiving parenteral nutrition * Has received any treatment for seizures * Clinical instability in the judgment of nurses/midwives and paediatricians looking after the baby and mother.

Design outcomes

Primary

MeasureTime frameDescription
Salivary cortisolImmediately before heel prick and 20 minutes afterChange between cortisol levels at baseline and 20 minutes after

Secondary

MeasureTime frameDescription
Heart rateBaseline, time of event, 20 mins after and 60 minutes afterChange from baseline heart rate to to time of event and two post test periods
Blood oxygenationBaseline, time of event, 20 mins after and 60 minutes afterChange from baseline oxygenation levels to time of event and two post test periods

Countries

United Kingdom

Contacts

Primary ContactFrancis McGlone, Professor
F.P.McGlone@ljmu.ac.uk0151 904 6332
Backup ContactLaura Mulligan
l.a.mulligan@2017.ljmu.ac.uk0151 904 6332

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026